Skip to main content

Skyrizi (Risankizumab-Rzaa) & Signal Identification

    Basic Details
    Status
    Ongoing
    Last Updated
    Tuesday, October 1, 2024
    Original Posting Date
    Health Outcome(s)
    signal identification
    Purpose
    Signal Identification
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    No